Who mentions $VVOS most on Surfaced?

@acinvestorblog (Antonio Costa) mentions $VVOS most — 46 mentions in the past 12 months.

When was $VVOS first mentioned on Surfaced?

The earliest tracked mention of $VVOS in the Surfaced archive was on Dec 16, 2025.

How many voices track $VVOS?

1 FinTwit voice has mentioned $VVOS 46 times in the past 12 months.

What kind of voices mention $VVOS most?

$VVOS is mentioned most by Long Research voices on Surfaced.

$VVOS — FinTwit mentions on Surfaced

Recent mentions

46 mentions

@acinvestorblogJun 30, 2026 · 1:43 PM

$VVOS great news this morning... -15% ???

Open on X

@acinvestorblogJun 30, 2026 · 12:45 PM

$VVOS Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

Open on X

@acinvestorblogJun 22, 2026 · 12:32 PM

$VVOS Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Open on X

@acinvestorblogJun 18, 2026 · 4:35 PM

$VVOS trading at 45c on very low volume. On March 31, Michael Skaff acquired over 1.3 million shares at an average price of $1.34 https://t.co/X2p1fOLZ8t

Open on X

@acinvestorblogJun 10, 2026 · 2:13 PM

$VVOS had great news this morning.

Open on X

@acinvestorblogJun 10, 2026 · 1:04 PM

$VVOS Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

Open on X

@acinvestorblogJun 5, 2026 · 2:04 PM

$VVOS 💪

Open on X

@acinvestorblogJun 5, 2026 · 9:30 AM

@ChrisLaCoursie1 I still waiting on $VVOS

Open on X

@acinvestorblogMay 20, 2026 · 8:10 PM

$VVOS Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update https://t.co/gxJIvbofyt

Open on X

@acinvestorblogApr 23, 2026 · 7:31 PM

$VVOS -16% on just 500K shares, while a major holder just stepped up big with $2.25M fresh capital and now owns nearly 20%. Strong vote of confidence at these prices. When smart money doubles down at these depressed prices, it’s worth paying attention. Watching closely.

Open on X

@acinvestorblogApr 17, 2026 · 3:38 PM

$VVOS Just out: HC Wainwright maintains Buy rating but lowers price target to $2.5 (150% PREMIUM vs current price)

Open on X

@acinvestorblogApr 17, 2026 · 3:02 PM

$VVOS Keep in mind. V-Co Investors 3 LLC (an affiliate of New Seneca Partners Inc. and 10% owner associated with Michael C. Skaff) took a significant position in Vivos Therapeutics via a private placement that closed on March 31, 2026 Purchasing 1,353,625 shares of common stock at $1.34 per share. Stock is trading at $1 as i type. They believe in the company with Big Bucks

Open on X

@acinvestorblogApr 15, 2026 · 8:24 PM

$VVOS Vivos Therapeutics Reports Full Year 2025 Financial Results https://t.co/uEo20Pi54b

Open on X

@acinvestorblogApr 15, 2026 · 2:17 PM

$VVOS at breakout point

Open on X

@acinvestorblogApr 15, 2026 · 1:40 PM

$NKE solid action so far. $VVOS breakout/squeeze watch over 1.42

Open on X

@acinvestorblogApr 15, 2026 · 12:59 PM

$VVOS plans to release its full year 2025 financial results after market close today. Since 2024, Seneca affiliates have invested a total of $13.4 million in the company. The proceeds will support general working capital and help advance Vivos’ medical affiliation model for its innovative Vivos device in treating obstructive sleep apnea. This continued backing from a key investor adds momentum and makes VVOS an interesting name to watch in the sleep health space. The upperline of this large falling wedge lies at 1.42 any break and the move could accelearte quickly. VVOS is definitely a name to watch. I like it a lot.

Open on X

@acinvestorblogApr 15, 2026 · 12:03 PM

$VVOS Check out this great video on the Vivos Therapeutics website that beautifully explains the Vivos device and how it’s helping people improve their sleep and breathing naturally. Vivos could become a notable name in sleep medicine and dental sleep therapy. The OSA market is large enough for a successful niche player to thrive and potentially get acquired or expand significantly. It’s an interesting high-risk/high-reward story with real technological differentiation. Recent quarters have shown revenue acceleration, expansion into medical/sleep center affiliations, and analyst price targets suggesting significant upside. Do your own DD.

Open on X

@acinvestorblogApr 15, 2026 · 7:34 AM

@Gubloinvestor Some of my fav $FNUC (uranium junior name with great projects) $VVOS (Vivos Therapeutics’ CARE appliances (including the DNA appliance) are currently the only ones with specific FDA 510(k) clearance for treating moderate-to-severe obstructive sleep apnea in adults using a non-surgical oral device).

Open on X

@acinvestorblogApr 14, 2026 · 6:40 PM

$VVOS worth watching. Vivos CEO Explains Breakthrough Sleep Apnea Tech and Path to Profitability https://t.co/odYkZ8UA61 CEO highlighted: “Well, we all want to be that unicorn, right? We all want to be that next unicorn…” - Current valuation being “very understated.” - Strong clinical data (including the March-highlighted study). - Path to profitability and breakeven targeted for end of 2026 - Significant market opportunity (millions of untreated OSA patients who dislike CPAP). - The scalability of the new physician-owned / in-network sleep center model.

Open on X

@acinvestorblogApr 14, 2026 · 2:44 PM

$VVOS nice volume on this one. Note: V-Co Investors 3 LLC took a nice-sized position in Vivos Therapeutics at the end of March 2026. It's a bullish signal from a repeat institutional investor (they're doubling down).

Open on X

@acinvestorblogApr 7, 2026 · 7:55 PM

$VVOS pulled back on very low volume.

Open on X

@acinvestorblogApr 6, 2026 · 2:38 PM

$VVOS follow the flow https://t.co/Ym4rYlhjJw

Open on X

@acinvestorblogApr 6, 2026 · 1:38 PM

$VVOS Keep an eye on it. Great news 👇 https://t.co/VjOi3AJmlz

Open on X

@acinvestorblogApr 6, 2026 · 1:03 PM

$VVOS nice volume in pre-market following Thursday Form 4 https://t.co/n0LUqZwI71

Open on X

@acinvestorblogMar 27, 2026 · 7:30 PM

$VVOS Buyers into the close.... great research note by WTR this afternoon.

Open on X

@acinvestorblogMar 27, 2026 · 6:46 PM

$VVOS 👇 We just need a good market enviroment now following yesterday CEO news. Stock moves fast. https://t.co/RKFKncozkq

Open on X

@acinvestorblogMar 27, 2026 · 6:16 PM

$VVOS 👇👇👇

Open on X

@acinvestorblogMar 26, 2026 · 5:24 PM

$VVOS Here we go...... breaking out ... step by step

Open on X

@acinvestorblogMar 26, 2026 · 3:23 PM

$VVOS new intraday high, interesting

Open on X

@acinvestorblogMar 26, 2026 · 2:07 PM

$VVOS is a small-cap biotech name that has a history of big bounces from deeply oversold levels. It released some good news today, so I’d keep it on your watchlist. Daily time-frame https://t.co/5gOCek7Efj

Open on X

@acinvestorblogMar 26, 2026 · 1:49 PM

$VVOS cash flow positive during fiscal year 2026 - Great press release this morning "Vivos believes this major development has the potential to positively and significantly impact patient access to Vivos’ patented OSA treatments and resulting top-line revenue and overall profitability from operations in its key treatment market of Las Vegas, NV."

Open on X

@acinvestorblogMar 26, 2026 · 12:47 PM

$VVOS Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - Insurance Coverage on Vivos Appliances and Treatment Now Available to a Significant Number of Nevada Patients Previously Unable to Access Coverage - Concurrently, Vivos Implements Cost Reduction Initiatives Related to Legacy Business Model to Focus on Scaling its Medical Affiliation Distribution Model

Open on X

@acinvestorblogMar 17, 2026 · 12:46 PM

$VVOS Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy https://t.co/3NT0U4KZ50

Open on X

@acinvestorblogMar 11, 2026 · 3:51 PM

$VVOS volume is coming in

Open on X

@acinvestorblogMar 11, 2026 · 3:07 PM

$VVOS another small bio name on the verge of a technical breakout. On watch. https://t.co/HhN6ATpwtj

Open on X

@acinvestorblogFeb 5, 2026 · 1:45 PM

$VVOS Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Open on X

@acinvestorblogFeb 2, 2026 · 3:44 PM

$VVOS has that look. https://t.co/Fiu7eBI2JG

Open on X

@acinvestorblogJan 30, 2026 · 8:23 PM

$VVOS finally seeing big buy orders on the system today.

Open on X

@acinvestorblogJan 30, 2026 · 6:13 PM

$VVOS surprise surprise , Vanguard Group disclosed yesterday a 232% increase position on Vivos. https://t.co/3mQumSMIJa

Open on X

@acinvestorblogJan 29, 2026 · 6:39 PM

$VVOS 1.60 crazy price 😲 The Price-to-Sales (P/S) ratio for Vivos Therapeutics (VVOS), a micro-cap medical device company focused on sleep apnea treatments, is approximately 0.8x (trailing twelve months, TTM) as of late January 2026. VVOS trades at a very low multiple

Open on X

@acinvestorblogJan 9, 2026 · 8:52 PM

$NBY a small bio name on an EPIC short squeeze .... 🤣🤣 can i dream with a similar type-move on $VVOS $GNPX or $VTGN ?

Open on X

@acinvestorblogJan 9, 2026 · 8:22 PM

$VVOS is pulling back on very low volume. Watch for a reversal here. https://t.co/rRYvcEDzJ3

Open on X

@acinvestorblogJan 2, 2026 · 9:22 PM

$VVOS Big engulfing candle today. Bullish reversal candle. https://t.co/QPJwEjLZ8w

Open on X

@acinvestorblogJan 2, 2026 · 4:51 PM

$VVOS 🤫🤫🤫🤫

Open on X

@acinvestorblogDec 17, 2025 · 8:10 PM

$VVOS Stupidity and irrationality happen in pullbacks.... This company is now trading with a PS of 0.96 , yup you read it right price-to-sales is 0.96 A price-to-sales (P/S) ratio below 1 often signals potential undervaluation. Yesterday, the company announced the grand opening of a new affiliated sleep testing and treatment center in Auburn Hills, Michigan (near Detroit), in partnership with MISleep Solutions. This marks geographic expansion beyond the Las Vegas area and demonstrates the scalability of its capital-efficient affiliation model. In Nov, the company delivered strong results with revenue of $6.8 million, up 76% year-over-year and 78% sequentially from Q2. This growth was primarily driven by the first full quarter of operations from the June 2025 acquisition of The Sleep Center of Nevada (SCN), which contributed significantly to diagnostic testing and treatment revenue. Gross profit rose to $3.9 million (58% margin), though operating losses persisted amid integration costs. Insane seeing the stock below $2

Open on X

@acinvestorblogDec 16, 2025 · 1:46 PM

$VVOS Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, MichiganVivos Eyes High Growth Potential from Commercial Affiliation with Prominent Auburn Hills, Michigan Sleep Practice MISleep Solutions

Open on X

Frequently asked